Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial (2019)
- Authors:
- Autor USP: DRAGER, LUCIANO FERREIRA - FM
- Unidade: FM
- DOI: 10.1016/j.soard.2018.11.022
- Subjects: HIPERTENSÃO; FATORES DE RISCO; DERIVAÇÃO GÁSTRICA; DOENÇAS METABÓLICAS; CARDIOPATIAS; ENSAIO CLÍNICO; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Surgery for obesity and related diseases
- ISSN: 1550-7289
- Volume/Número/Paginação/Ano: v. 15, n. 2, p. 211-217, 2019
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
SCHIAVON, Carlos Aurelio et al. Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial. Surgery for obesity and related diseases, v. 15, n. 2, p. 211-217, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.soard.2018.11.022. Acesso em: 12 mar. 2026. -
APA
Schiavon, C. A., Santos, R. N., Santucci, E. V., Noujaim, P. M., Cavalcanti, A. B., & Drager, L. F. (2019). Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial. Surgery for obesity and related diseases, 15( 2), 211-217. doi:10.1016/j.soard.2018.11.022 -
NLM
Schiavon CA, Santos RN, Santucci EV, Noujaim PM, Cavalcanti AB, Drager LF. Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial [Internet]. Surgery for obesity and related diseases. 2019 ; 15( 2): 211-217.[citado 2026 mar. 12 ] Available from: https://doi.org/10.1016/j.soard.2018.11.022 -
Vancouver
Schiavon CA, Santos RN, Santucci EV, Noujaim PM, Cavalcanti AB, Drager LF. Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial [Internet]. Surgery for obesity and related diseases. 2019 ; 15( 2): 211-217.[citado 2026 mar. 12 ] Available from: https://doi.org/10.1016/j.soard.2018.11.022 - We thank Dr. Ege for the support and insightful comments regarding the Sleep and Stent Study... [Carta]
- Impact of Compression Stockings vs. Continuous Positive Airway Pressure on Overnight Fluid Shift and Obstructive Sleep Apnea among Patients on Hemodialysis
- Update in Sleep-disordered Breathing 2016
- Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science
- Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?
- Sleep Disturbances and Resistant Hypertension: Association or Causality?
- Cardiomiopatia e apneia obstrutiva do sono
- Determinantes das propriedades funcionais e estruturais de grandes artérias em indivíduos saudáveis
- Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk
- Management of Hypertension in Obstructive Sleep Apnea
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
